SECRETARY'S UPDATE
 |
John C. Morris, M.D.
ATA Secretary/
Chief Operating Officer |
Dear colleagues,
I am happy to announce that spring has arrived. Not in terms of the weather in Minnesota or the Northern Hemisphere but, at least, the days are longer and the light on the snow is heartening.
ATA Satellite
As you are making plans to attend the International Congress of Endocrinology (ICE) / Endocrine Society Meeting in Chicago, don't forget to arrive in time for the afternoon ATA symposium on Friday, June 20, 2014 "American Thyroid Association (ATA) Guidelines on Thyroid Nodules and Differentiated Thyroid Cancer — Highlights, Consensus, and Controversies". This event, which is being presented as a satellite of the ICE/Endocrine Society meeting is a new concept for the ATA and will serve as a roll out of the anticipated and updated thyroid nodule and thyroid cancer guidelines. In presenting our most high-profile guideline at this international endocrine meeting, we expect to generate great interest from a large audience of specialists who utilize these guidelines in everyday clinical practice. This symposium will be the culmination of a long process of revision as the task force, chaired by Bryan Haugen, has updated the guidelines with the latest evidence and recommendations. The task force faculty will highlight areas of the guidelines that have changed significantly since 2009 and include discussions of new evidence which gives the rationale for recommendations. Conveniently, the meeting location is combined with the ICE/ENDO program and registration in the convention center. ATA members who do not belong to the Endocrine Society should use a code (ATAMEM) or, if a trainee (ATATRN) to receive a member discount as you register online http://registration3.experientevent.com/showend141/. For information about the program, go to https://endo.confex.com/endo/2014endo/webprogram/Session4038.html
U.S. Prescribing Information for Thyrogen Revised to Include Use of Wider Range of Radioiodine in Patients
Revised label will facilitate use of Thyrogen to greater number of patients for postoperative thyroid remnant ablation, March 27, 2014
CAMBRIDGE, Mass. – Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the Food and Drug Administration (FDA) approved revised prescribing information for the use of Thyrogen® (thyrotropin alfa for injection) to widen the dose range of radioiodine (RAI) when used for thyroid remnant ablation. Read More…
THYROGEN® Highlights of Prescribing Information (PDF File, 666KB)
2014 ATA Annual Fund Donors
134 ATA members, family members and staff have donated a total of $54,742 to the 2014 Annual Fund beginning October 1, 2013. These funds are dedicated to support of:
- ATA Scientific Lectures and Symposia
- ATA Trainees Education
- ATA Research Grants
- ATA Patient Resources
Donations received between October 1, 2013 and March 31, 2014
Thyroid Awareness monthly campaigns announced in cooperation with PuraVida
The ATA will be highlighting a distinct thyroid disorder each month and a portion of the sales for PuraVida bracelets will be donated to the ATA. The thyroid disorder designated for awareness this month is Hypothyroidism and a bracelet to show support for awareness and education about this thyroid condition is available through the ATA Marketplace.
ATA thyroid surveys
Post-Operative Management of Hypocalcemia in Thyroidectomy Patients
We are conducting a survey regarding the post-operative management of hypocalcemia in thyroidectomy patients.
If you are a THYROID SURGEON, please take this survey
If you are an ENDOCRINOLOGIST, please take this survey
RAI-Induced Sialadenitis and its Treatment Survey
We are conducting a study whose goal is to assess the awareness of medical practitioners with regards to RAI-induced sialadenitis and its treatment.
RAI-Induced Sialadenitis and its Treatment Survey
VideoEndocrinology™ Call for Videos
Launching Spring 2014 Thyroid, the preeminent journal in the field covering research and practice, and the official journal of the American Thyroid Association, has expanded to include an innovative video component, VideoEndocrinology™ (VE). Read More…
Read More ... 2014 Call for Awards and Officers Nominations
The American Thyroid Association is now accepting nominations for its 2014 Awards.
Nominate a colleague who exemplifies outstanding professionalism, dedication and contributions in the field of thyroidology. The awards will be presented at the 84th Annual Meeting of the ATA in Coronado, California, October 29 — November 2, 2014.
The deadline for nominations is March 31. Awards description, criteria and nomination forms are available online. For more information contact scano@throid.org.
Call for Nominations for Awards (PDF File, 181 KB)
The American Thyroid Association is now accepting nominations for its 2014 Officers.
In accordance with the Bylaws of the American Thyroid Association, the Nominating Committee is soliciting nominations from the membership for candidates for the offices of President and Directors (3) to serve on the ATA Board of Directors. Candidates will be selected by the Nominating Committee and submitted to the ATA Board for final approval. A ballot will be sent to the membership electronically in August 2014. Newly elected Board members will be announced at the Annual Business Meeting on Thursday, October 30, 2014. All nominations must be submitted to the Executive Director, Bobbi Smith, by letter, fax, or e-mail bsmith@thyroid.org by March 31, 2014.
Call for Nominations for Board of Directors and Officers (PDF File, 137 KB)
Upcoming ATA Meetings
Career Center
 Check out the latest openings from Career Center
Governance – COI forms requested of all ATA Committee, Task Force, Working Group and Writing Group Members
Documents supporting good governance are available -- simply log into Members Only, click the Governance link and you will find the forms located near the top of the page.
American Thyroid Association, Inc. |
| 
